CRDMO Adopts ValGenesis for Digital Validation at New APAC Facility
Event summary
- A global CRDMO has selected ValGenesis to digitalize validation activities at its new greenfield facility in APAC.
- The deployment will support equipment qualification and computerized system validation, establishing a standardized digital approach from the outset.
- The implementation is part of the CRDMO's broader effort to modernize validation practices, expand automation, and strengthen data integrity.
- The CRDMO market is projected to nearly double over the next five years, increasing demand for scalable validation frameworks.
The big picture
As biopharmaceutical companies increasingly outsource drug development and manufacturing, the CRDMO market is expanding rapidly. This deal highlights the strategic importance of digital validation frameworks in supporting scalable, compliant operations. The adoption of ValGenesis' platform by a global CRDMO underscores the industry's shift towards automation and data integrity as key competitive differentiators.
What we're watching
- Market Growth
- How the projected doubling of the CRDMO market will impact demand for scalable validation solutions.
- Digital Adoption
- The pace at which other CRDMOs adopt digital validation frameworks to support long-term growth.
- Regulatory Compliance
- Whether the standardized digital approach will enhance inspection readiness and compliance for the CRDMO.
Related topics